| European Case Law Identifier: | ECLI:EP:BA:2012:T200308.20121031 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 31 October 2012 | ||||||||
| Case number: | T 2003/08 | ||||||||
| Application number: | 96941378.0 | ||||||||
| IPC class: | A61K 35/14 A61P 9/00 C07K 1/22 A61M 1/36 C07K 14/72 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Treatment of dilated cardiomyopathy by removal of autoantibodies | ||||||||
| Applicant name: | Edwards Lifesciences Corporation Reinke, Petra Brehme, Stefan Baumann, Gert Felix, Stephan |
||||||||
| Opponent name: | Fresenius Medical Care Deutschland GmbH | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | "Request not to hear a witness due to failure to reply to the invitation in accordance with Rule 118(c) EPC (refused)"; "Request for referral of questions to the Enlarged Board of Appeal (refused)"; Main request: added subject-matter (yes) Auxiliary request: claims to be interpreted as relating to a second medical use (yes) - means used in the treatment to be considered as a substance or composition in the sense of decision G 5/83; oral disclosure at a lecture - evidence from the lecturer and a member of the audience may be sufficient to establish the oral disclosure - contrary to the application by the first instance of decision T 1212/97; oral disclosure and prior use - established beyond reasonable doubt (no); conformity of the claims with the requirements of the EPC (yes) |
||||||||
| Catchwords: |
see points 6 to 21 and 30 to 48 |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t082003eu2.html
Date retrieved: 17 May 2021